Literature DB >> 21820559

Genetic techniques in Trypanosoma cruzi.

Martin C Taylor1, Huan Huang, John M Kelly.   

Abstract

It is almost 20 years since genetic manipulation of Trypanosoma cruzi was first reported. In this time, there have been steady improvements in the available vector systems, and the applications of the technology have been extended into new areas. Episomal vectors have been modified to enhance the level of expression of transfected genes and to facilitate the sub-cellular location of their products. Integrative vectors have been adapted to allow the development of inducible expression systems and the construction of vectors which enable genome modification through telomere-associated chromosome fragmentation. The uses of reverse genetic approaches to dissect peroxide metabolism and the mechanisms of drug activity and resistance in T. cruzi are illustrated in this chapter as examples of how the technology has been used to investigate biological function. Although there remains scope to improve the flexibility of these systems, they have made valuable contributions towards exploiting the genome sequence data and providing a greater understanding of parasite biology and the mechanisms of infection.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21820559     DOI: 10.1016/B978-0-12-385863-4.00011-3

Source DB:  PubMed          Journal:  Adv Parasitol        ISSN: 0065-308X            Impact factor:   3.870


  9 in total

Review 1.  State-of-the-art CRISPR/Cas9 Technology for Genome Editing in Trypanosomatids.

Authors:  Noelia Lander; Miguel A Chiurillo
Journal:  J Eukaryot Microbiol       Date:  2019-07-07       Impact factor: 3.346

2.  CRISPR/Cas9-Induced Disruption of Paraflagellar Rod Protein 1 and 2 Genes in Trypanosoma cruzi Reveals Their Role in Flagellar Attachment.

Authors:  Noelia Lander; Zhu-Hong Li; Sayantanee Niyogi; Roberto Docampo
Journal:  MBio       Date:  2015-07-21       Impact factor: 7.867

Review 3.  High throughput screening for anti-Trypanosoma cruzi drug discovery.

Authors:  Julio Alonso-Padilla; Ana Rodríguez
Journal:  PLoS Negl Trop Dis       Date:  2014-12-04

4.  Overexpression of Trypanosoma cruzi High Mobility Group B protein (TcHMGB) alters the nuclear structure, impairs cytokinesis and reduces the parasite infectivity.

Authors:  Luis Emilio Tavernelli; Maria Cristina M Motta; Camila Silva Gonçalves; Marcelo Santos da Silva; Maria Carolina Elias; Victoria Lucia Alonso; Esteban Serra; Pamela Cribb
Journal:  Sci Rep       Date:  2019-01-17       Impact factor: 4.379

5.  Stage-regulated GFP Expression in Trypanosoma cruzi: applications from host-parasite interactions to drug screening.

Authors:  Rafael Luis Kessler; Daniela Fiori Gradia; Rita de Cássia Pontello Rampazzo; Édio Elígio Lourenço; Nilson José Fidêncio; Lauro Manhaes; Christian Macagnan Probst; Andréa Rodrigues Ávila; Stenio Perdigão Fragoso
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

6.  A parent-of-origin effect determines the susceptibility of a non-informative F1 population to Trypanosoma cruzi infection in vivo.

Authors:  Grace K Silva; Larissa D Cunha; Catarina V Horta; Alexandre L N Silva; Fredy R S Gutierrez; João S Silva; Dario S Zamboni
Journal:  PLoS One       Date:  2013-02-11       Impact factor: 3.240

Review 7.  Genetic dissection of drug resistance in trypanosomes.

Authors:  Sam Alsford; John M Kelly; Nicola Baker; David Horn
Journal:  Parasitology       Date:  2013-04-03       Impact factor: 3.234

8.  RNAi in Arthropods: Insight into the Machinery and Applications for Understanding the Pathogen-Vector Interface.

Authors:  Annette-Christi Barnard; Ard M Nijhof; Wilma Fick; Christian Stutzer; Christine Maritz-Olivier
Journal:  Genes (Basel)       Date:  2012-11-06       Impact factor: 4.096

9.  Optimising genetic transformation of Trypanosoma cruzi using hydroxyurea-induced cell-cycle synchronisation.

Authors:  Francisco Olmo; Fernanda C Costa; Gurdip Singh Mann; Martin C Taylor; John M Kelly
Journal:  Mol Biochem Parasitol       Date:  2018-07-07       Impact factor: 1.759

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.